Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 292

    1.

    Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein.

    Abedini MR, Muller EJ, Bergeron R, Gray DA, Tsang BK.

    Oncogene. 2009 Oct 5. [Epub ahead of print]PMID: 19802016 [PubMed - as supplied by publisher]Related articles

    2.

    Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats?

    Roudier E, Chapados N, Decary S, Gineste C, Le Bel C, Lavoie JM, Bergeron R, Birot O.

    J Physiol. 2009 Aug 15;587(Pt 16):4105-19. Epub 2009 Jun 22.PMID: 19546164 [PubMed - in process]Related articles

    3.

    Vibriobactin antibodies: a vaccine strategy.

    Bergeron RJ, Bharti N, Singh S, McManis JS, Wiegand J, Green LG.

    J Med Chem. 2009 Jun 25;52(12):3801-13.PMID: 19492834 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prolonged voluntary wheel-running stimulates neural precursors in the hippocampus and forebrain of adult CD1 mice.

    Bednarczyk MR, Aumont A, Décary S, Bergeron R, Fernandes KJ.

    Hippocampus. 2009 Oct;19(10):913-27.PMID: 19405143 [PubMed - in process]Related articles

    5.

    Desferrithiocin analogue uranium decorporation agents.

    Bergeron RJ, Wiegand J, Singh S.

    Int J Radiat Biol. 2009 Apr;85(4):348-61.PMID: 19399680 [PubMed - indexed for MEDLINE]Related articles

    6.

    Fatty acid oxidation is decreased in the liver of ovariectomized rats.

    Paquette A, Chapados NA, Bergeron R, Lavoie JM.

    Horm Metab Res. 2009 Jul;41(7):511-5. Epub 2009 Feb 24.PMID: 19241328 [PubMed - indexed for MEDLINE]Related articles

    7.

    Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior.

    Basu AC, Tsai GE, Ma CL, Ehmsen JT, Mustafa AK, Han L, Jiang ZI, Benneyworth MA, Froimowitz MP, Lange N, Snyder SH, Bergeron R, Coyle JT.

    Mol Psychiatry. 2009 Jul;14(7):719-27. Epub 2008 Dec 9.PMID: 19065142 [PubMed - indexed for MEDLINE]Related articles

    8.

    Desferrithiocin analogues and nephrotoxicity.

    Bergeron RJ, Wiegand J, McManis JS, Bharti N, Singh S.

    J Med Chem. 2008 Oct 9;51(19):5993-6004. Epub 2008 Sep 13.PMID: 18788724 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    D1 and D4 dopaminergic receptor interplay mediates coincident G protein-independent and dependent regulation of glutamate NMDA receptors in the lateral amygdala.

    Martina M, Bergeron R.

    J Neurochem. 2008 Sep;106(6):2421-35. Epub 2008 Jul 24.PMID: 18662324 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparison of postvaccinal milk drop in dairy cattle vaccinated with one of two different commercial vaccines.

    Bergeron R, Elsener J.

    Vet Ther. 2008 Summer;9(2):141-6.PMID: 18597252 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells.

    Abedini MR, Muller EJ, Brun J, Bergeron R, Gray DA, Tsang BK.

    Cancer Res. 2008 Jun 15;68(12):4511-7.PMID: 18559494 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues.

    Bergeron RJ, Wiegand J, McManis JS, Bharti N, Singh S.

    J Med Chem. 2008 Jul 10;51(13):3913-23. Epub 2008 Jun 6.PMID: 18533709 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Validité et utilité clinique d'une grille d'observation (PACSLAC-F) pour évaluer la douleur chez des aînés atteints de démence vivant en milieu de soins de longue durée.

    Aubin M, Verreault R, Savoie M, Lemay S, Hadjistavropoulos T, Fillion L, Beaulieu M, Viens C, Bergeron R, Vézina L, Misson L, Fuchs-Lacelle S.

    Can J Aging. 2008 Spring;27(1):45-55.PMID: 18492636 [PubMed - in process]Related articles

    14.

    Sustained saturating level of glycine induces changes in NR2B-containing-NMDA receptor localization in the CA1 region of the hippocampus.

    Imamura Y, Ma CL, Pabba M, Bergeron R.

    J Neurochem. 2008 Apr 17. [Epub ahead of print]PMID: 18331477 [PubMed - as supplied by publisher]Related articles

    15.

    [The implications of the hospitalist phenomenon]

    Lehmann F, Brunelle Y, Dawes M, Boulé R, Bergeron R.

    Can Fam Physician. 2007 Dec;53(12):2131. Review. French. PMID: 18077751 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.

    Bergeron RJ, Wiegand J, Bharti N, Singh S, Rocca JR.

    J Med Chem. 2007 Jul 12;50(14):3302-13. Epub 2007 Jun 12.PMID: 17564424 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Solute-induced dissolution of hydrophobic ionic liquids in water.

    Rickert PG, Stepinski DC, Rausch DJ, Bergeron RM, Jakab S, Dietz ML.

    Talanta. 2007 Apr 15;72(1):315-20. Epub 2006 Nov 20.PMID: 19071621 [PubMed - in process]Related articles

    18.

    Endogenous N-acetylaspartylglutamate reduced NMDA receptor-dependent current neurotransmission in the CA1 area of the hippocampus.

    Bergeron R, Imamura Y, Frangioni JV, Greene RW, Coyle JT.

    J Neurochem. 2007 Jan;100(2):346-57.PMID: 17241157 [PubMed - indexed for MEDLINE]Related articles

    19.

    Impact of an educational program on pain management in patients with cancer living at home.

    Aubin M, Vézina L, Parent R, Fillion L, Allard P, Bergeron R, Dumont S, Giguère A.

    Oncol Nurs Forum. 2006 Nov 27;33(6):1183-8.PMID: 17149401 [PubMed - indexed for MEDLINE]Related articles

    20.

    Placebo-controlled double-blind clomipramine trial for the treatment of anxiety or fear in beagles during ground transport.

    Frank D, Gauthier A, Bergeron R.

    Can Vet J. 2006 Nov;47(11):1102-8.PMID: 17147141 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The design, synthesis, and evaluation of organ-specific iron chelators.

    Bergeron RJ, Wiegand J, McManis JS, Bharti N.

    J Med Chem. 2006 Nov 30;49(24):7032-43.PMID: 17125256 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    The sigma-1 receptor modulates NMDA receptor synaptic transmission and plasticity via SK channels in rat hippocampus.

    Martina M, Turcotte ME, Halman S, Bergeron R.

    J Physiol. 2007 Jan 1;578(Pt 1):143-57. Epub 2006 Oct 26.PMID: 17068104 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Cultural stereotypes die hard: the case of transracial adoption.

    Griffith EE, Bergeron RL.

    J Am Acad Psychiatry Law. 2006;34(3):303-14.PMID: 17032953 [PubMed - indexed for MEDLINE]Related articles

    24.

    Broad cognitive abilities of children with mental retardation: an analysis of group and individual profiles.

    Bergeron R, Floyd RG.

    Am J Ment Retard. 2006 Nov;111(6):417-32.PMID: 17029499 [PubMed - indexed for MEDLINE]Related articles

    25.

    Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.

    Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW.

    Endocrinology. 2006 Sep;147(9):4252-62. Epub 2006 May 25.PMID: 16728496 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    (S)-4,5-dihydro-2-(2-hydroxy-4-hydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid polyethers: a solution to nephrotoxicity.

    Bergeron RJ, Wiegand J, McManis JS, Vinson JR, Yao H, Bharti N, Rocca JR.

    J Med Chem. 2006 May 4;49(9):2772-83.PMID: 16640338 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Regulatory impact of intra-hepatic carbohydrate and lipid metabolism.

    Lavoie JM, Bergeron R, Latour MG.

    Can J Appl Physiol. 2005 Jun;30(3):282-91.PMID: 16129893 [PubMed - indexed for MEDLINE]Related articles

    28.

    Luteal phase dosing with paroxetine controlled release (CR) in the treatment of premenstrual dysphoric disorder.

    Steiner M, Hirschberg AL, Bergeron R, Holland F, Gee MD, Van Erp E.

    Am J Obstet Gynecol. 2005 Aug;193(2):352-60.PMID: 16098854 [PubMed - indexed for MEDLINE]Related articles

    29.

    Polyamine-vectored iron chelators: the role of charge.

    Bergeron RJ, Bharti N, Wiegand J, McManis JS, Yao H, Prokai L.

    J Med Chem. 2005 Jun 16;48(12):4120-37.PMID: 15943485 [PubMed - indexed for MEDLINE]Related articles

    30.

    Role of the glycine site of the N-methyl-D-aspartate receptor in synaptic plasticity induced by pairing.

    Krasteniakov NV, Martina M, Bergeron R.

    Eur J Neurosci. 2005 May;21(10):2782-92.PMID: 15926925 [PubMed - indexed for MEDLINE]Related articles

    31.

    Synthesis and biological evaluation of aminopolyamines.

    Bergeron RJ, Huang G, McManis JS, Yao H, Nguyen JN.

    J Med Chem. 2005 May 5;48(9):3099-102.PMID: 15857111 [PubMed - indexed for MEDLINE]Related articles

    32.

    Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.

    Jiang G, Li Z, Liu F, Ellsworth K, Dallas-Yang Q, Wu M, Ronan J, Esau C, Murphy C, Szalkowski D, Bergeron R, Doebber T, Zhang BB.

    J Clin Invest. 2005 Apr;115(4):1030-8. Epub 2005 Mar 10. Erratum in: J Clin Invest. 2005 Aug;115(8):2297. PMID: 15761499 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Partition-variant desferrithiocin analogues: organ targeting and increased iron clearance.

    Bergeron RJ, Wiegand J, McManis JS, Weimar WR, Park JH, Eiler-McManis E, Bergeron J, Brittenham GM.

    J Med Chem. 2005 Feb 10;48(3):821-31.PMID: 15689166 [PubMed - indexed for MEDLINE]Related articles

    34.

    Comparison of iron chelator efficacy in iron-overloaded beagle dogs and monkeys (Cebus apella).

    Bergeron RJ, Wiegand J, Weimar WR, Lindstrom TC, Fannin TL, Ratliff-Thompson K.

    Comp Med. 2004 Dec;54(6):664-72.PMID: 15679265 [PubMed - indexed for MEDLINE]Related articles

    35.

    Reduced glycine transporter type 1 expression leads to major changes in glutamatergic neurotransmission of CA1 hippocampal neurones in mice.

    Martina M, B-Turcotte ME, Halman S, Tsai G, Tiberi M, Coyle JT, Bergeron R.

    J Physiol. 2005 Mar 15;563(Pt 3):777-93. Epub 2005 Jan 20.PMID: 15661817 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes.

    Petersen KF, Price TB, Bergeron R.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4656-64.PMID: 15356077 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    NAAG reduces NMDA receptor current in CA1 hippocampal pyramidal neurons of acute slices and dissociated neurons.

    Bergeron R, Coyle JT, Tsai G, Greene RW.

    Neuropsychopharmacology. 2005 Jan;30(1):7-16.PMID: 15354184 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Gene knockout of glycine transporter 1: characterization of the behavioral phenotype.

    Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS, Jiang Z, Caine SB, Coyle JT.

    Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8485-90. Epub 2004 May 24.PMID: 15159536 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Subthreshold contribution of N-methyl-d-aspartate receptors to long-term potentiation induced by low-frequency pairing in rat hippocampal CA1 pyramidal cells.

    Krasteniakov NV, Martina M, Bergeron R.

    Neuroscience. 2004;126(1):83-94.PMID: 15145075 [PubMed - indexed for MEDLINE]Related articles

    40.

    Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders.

    Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A.

    J Neurosci. 2004 Apr 7;24(14):3471-9.PMID: 15071094 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels.

    Martina M, Gorfinkel Y, Halman S, Lowe JA, Periyalwar P, Schmidt CJ, Bergeron R.

    J Physiol. 2004 Jun 1;557(Pt 2):489-500. Epub 2004 Apr 2.PMID: 15064326 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Polyamine-iron chelator conjugate.

    Bergeron RJ, McManis JS, Franklin AM, Yao H, Weimar WR.

    J Med Chem. 2003 Dec 4;46(25):5478-83.PMID: 14640556 [PubMed - indexed for MEDLINE]Related articles

    43.

    A new class of glycogen phosphorylase inhibitors.

    Lu Z, Bohn J, Bergeron R, Deng Q, Ellsworth KP, Geissler WM, Harris G, McCann PE, McKeever B, Myers RW, Saperstein R, Willoughby CA, Yao J, Chapman K.

    Bioorg Med Chem Lett. 2003 Nov 17;13(22):4125-8.PMID: 14592521 [PubMed - indexed for MEDLINE]Related articles

    44.

    Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.

    Ogawa AK, Willoughby CA, Bergeron R, Ellsworth KP, Geissler WM, Myers RW, Yao J, Harris G, Chapman KT.

    Bioorg Med Chem Lett. 2003 Oct 20;13(20):3405-8.PMID: 14505637 [PubMed - indexed for MEDLINE]Related articles

    45.

    Iron chelation promoted by desazadesferrithiocin analogs: An enantioselective barrier.

    Bergeron RJ, Wiegand J, Weimar WR, McManis JS, Smith RE, Abboud KA.

    Chirality. 2003 Aug;15(7):593-9.PMID: 12840823 [PubMed - indexed for MEDLINE]Related articles

    46.

    Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise.

    Coven DL, Hu X, Cong L, Bergeron R, Shulman GI, Hardie DG, Young LH.

    Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E629-36. Epub 2003 May 20.PMID: 12759223 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Methoxylation of desazadesferrithiocin analogues: enhanced iron clearing efficiency.

    Bergeron RJ, Wiegand J, McManis JS, Bussenius J, Smith RE, Weimar WR.

    J Med Chem. 2003 Apr 10;46(8):1470-7.PMID: 12672247 [PubMed - indexed for MEDLINE]Related articles

    48.

    Prevention of acetic acid-induced colitis by desferrithiocin analogs in a rat model.

    Bergeron RJ, Wiegand J, Weimar WR, Nguyen JN, Sninsky CA.

    Dig Dis Sci. 2003 Feb;48(2):399-407.PMID: 12643622 [PubMed - indexed for MEDLINE]Related articles

    49.

    D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons.

    Martina M, Krasteniakov NV, Bergeron R.

    J Physiol. 2003 Apr 15;548(Pt 2):411-23. Epub 2003 Feb 28.PMID: 12611916 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Structure-activity relationships among desazadesferrithiocin analogues.

    Bergeron RJ, Wiegand J, McManis JS, Weimar WR, Huang G.

    Adv Exp Med Biol. 2002;509:167-84. Review.PMID: 12572994 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...